Oh by the way, I forgot Let me make your post make sense.. What are you talking about? They can never self fund vitiligo? , they already did it once. Barda gave 25 million. For the studies for burns. Not vitiligo, what do you think they using the burn income To fund the vitiligo study? LOL- There is no income, that means anything.That’s why you’re at the bottom of the cliff looking up.They haven’t turned a profit, and that’s not what they’re using the proceeds for the Burns to do. Their self funding the vitiligo studies, so they did 120 million offering. Its called self funding. So yes they can afford it it’s called selling shares, it’s called dilution. Which knock two dollars off the share price from the previous high it was before the offering was complete. Which I didn’t have a problem with, because I knew the share value was going back up . Which is fine as long as it adds investor value. I didn’t like the fact that the CEO dump shares right after the offering.IDropping in another buck and a half . Old vitiligo are not antidotal, said in the filing, trying to use that data to speed the vitiligo process up by the end of the year. There i fixed it , now your post makes sense. So now hopefully you know why they did the switch, so I could start diluting again. They maxed out dilation in Australia it was getting too many two.1 billion is too many. Deposit all the way down to 20 million shares, I have 200 million in the treasury. Those will be out first of the year watch. If that wasn’t the plan to begin with there’s been no reason to bring it down 100 to 1. They tried to divert it from attention, and say they’re not gonna do it. I say they do it before April 1
News 
Market Data 
Discover 
AI
